Egyptian Drug Authority · Egypt
DEA-EG-2023-0013
Tier 1 · Regulator-publishedUnclassifiedRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(13) For2023
- Date issued
- Aug 2023
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Alveofact 108mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
أغسطس ٣٢٠٢
وذلـــك لكـــون المســـتحضر غير مطابق للمواصفات
يتم ضبط وتحريز كافة العبوات من المستحضر الموضح أدناه:
منشور
Alveofact 108 mg
رقم التشغيلة
2023/تاريخ الانتهاء
الشركة المستوردة للمنتج: فارماكونOriginal language: ar
- Notice text in English
- Circular, August 2023. All packs of the product described below are to be impounded and seized: Alveofact 108 mg, with the batch number and a 2023 expiry date as stated. The importing company is Pharmacon. The product does not conform to specification.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 644ecb50557006075b099678210ac8c61a683bc1a2e60eabd0c2a69fe4a903e1SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:55 UTC
Cite this record
Drug Eye Africa (2023). DEA-EG-2023-0013: Alveofact 108mg — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2023/dea-eg-2023-0013Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.